
Podcast episode guide
馃К Pfizer, AstraZeneca & Merck: Building Biotechs Within Big Pharma | Martin Brenner Rerelease (2/3)
This episode provides an insider's perspective on driving innovation within large pharmaceutical companies, crucial for understanding the biotech landscape.
- Series
- The Biotech Startups Podcast
- Published
- May 11, 2026
- Duration
- 37 min
- Format
- Podcast Episode
Overview
馃К Pfizer, AstraZeneca & Merck: Building Biotechs Within Big Pharma | Martin Brenner Rerelease (2/3) episode overview
What this episode covers
This episode provides an insider's perspective on driving innovation within large pharmaceutical companies, crucial for understanding the biotech landscape.
Startup context
Upseed's structured assessment connects this episode to Biotech & Life Sciences and Healthcare.
Who may find it useful
The episode may be useful to Founders, Investors, and Builders. This is a machine-assisted relevance assessment rather than a publisher claim.
Episode profile
Publication and format
These compact facts come from public podcast distribution metadata. Upseed does not host or reproduce the audio.
- Publication date
- May 11, 2026
- Duration
- 37 min
- Episode type
- Podcast Episode
- Series position
- Episode 240
- Explicit-content flag
- Not marked explicit
- Last assessed
- July 28, 2026
- Published
- May 11, 2026
- publisher-supplied date
- Duration
- 37 min
- publisher-supplied runtime
- Startup signals
- 2
- structured sectors, stages, and topics
- Last assessed
- July 28, 2026
- Upseed relevance review
Public podcast distribution metadata and Upseed's independent startup-relevance assessment 路 July 28, 2026
Startup sectors
Structured sector context
These links come from validated Sector codes in Upseed's Episode assessment. They describe subject matter, not endorsement or investment fit.
Series context
Podcast Series and connected producer
Continue to the Series guide for its broader focus, latest public destinations, and other startup Episodes.
Common questions
Using this Episode guide
No. Upseed independently organizes public startup information. The episode title, publication facts, artwork, and official destination originate from public podcast distribution metadata.
Source and update disclosure
Know what this page is based on
Source basis
Public podcast distribution metadata and structured Upseed relevance assessment.
Last reviewed
July 28, 2026
Known limits
Episode identity, publication date, duration, Series artwork, and listening destination come from public podcast distribution metadata. The visible summary, Sectors, stages, topics, audiences, personas, and inclusion are Upseed's machine-assisted assessment. Upseed does not publish the source description, show notes, audio or video URL, transcript, raw guest data, or unresolved mentions.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.